Diclofenac Sodium Tablet, Delayed Release
Product Images NDC 72888-110

This is a medication guide for Diclofenac Sodium Delayed-Release Tablets, USP. Each tablet contains 25 mg of Diclofenac Sodium which is used in the treatment of pain and inflammation. The recommended dosage is specified in the package insert. The tablets should be stored at room temperature between 20°C and 25°C, protected from moisture, and dispensed in a tight, light-resistant container. The medication is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India. A medication guide should be provided to each patient.*

Each delayed-release tablet contains 25mg of Diclofenac Sodium, USP. The usual dosage can be found in the package insert. It should be stored at room temperature, between 20°C to 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F and 86°F). The tablets should be protected from moisture and dispensed in a tight and light-resistant container. The medication guide is available at WWW-advagenpharma.com/medguide/diclofenacsodium. It is important to keep this and all drugs out of reach of children. Each package contains 100 tablets, for the exclusive use of prescription holders.*

Diclofenac Sodium is a medication dispensed in a tight, light-resistant container. The medication guide should be printed to give to each patient. The tablets should be stored at room temperature and protected from moisture. Each delayed-release tablet contains 25mg of Diclofenac Sodium USP. The usual dosage is not available. The drug should be kept away from children. The distributor is Advagen Pharma Limited, located in Plainsboro, NJ. The drug is manufactured by Rubicon Research Private Limited, in Ambernath, India.*

Each delayed-release tablet contains 25mg of Diclofenac Sodium. The usual dosage is indicated in the package insert. The tablets should be stored in a container at room temperature. Protect from moisture. Dispense in a tight, light-resistant container. This medication should be kept out of the reach of children. This drug is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited. The medication guide should be dispersed to each patient by the pharmacist.*

This is a description of a medication called Diclofenac Sodium. The medication has a delayed-release formulation and each tablet contains 50mg of Diclofenac Sodium USP. The usual dosage is to be determined by the package insert. The medication should be stored within an appropriate temperature range of 20°C to 25°C or 68°F to 77°F, with excursions allowed between 15°C to 30°C or 59°F to 86°F. It should be protected from moisture and dispensed in a tight, light-resistant container. This medication should be kept out of reach of children. It comes with an accompanying Medication Guide to be dispensed by the pharmacist to each patient. The medication is distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India.*

This is a medication called Diclofenac Sodium, with each delayed-release tablet containing 50mg. The recommended storage temperature is between 20°C to 25°C. The medication guide should be dispersed to each patient by the pharmacist. The medication should be kept out of reach of children. The medication is distributed by Advagen Pharma Limited and is manufactured by Rubicon Research Private Limited. The manufacturing license number is KD-682. The other text suggests information about dosage, packaging, and printing.*

Each delayed-release tablet of Diclofenac Sodium, USP contains 50mg. The medication should be stored at room temperature between 20°C to 25°C (68°F to 77°F) and protected from moisture. It should be dispensed in a light, airtight, moisture-resistant container. The usual dosage can be found in the package insert, and additional information can be found in the medication guide provided at www.advagenpharma.com/medguide/. The tablets are distributed by Adt Ph Limited in Plainsboro, NJ and manufactured by Rubicon Research Private Limited in India. Pharmacists are advised to check medication before dispensing it to customers.*

This is a medication description for Diclofenac Sodium Delayed-Release Tablets. Each tablet contains 75 mg of Diclofenac Sodium, USP. The usual dosage can be found in the package insert, and the tablets should be stored at room temperature and protected from moisture. These tablets are intended for prescription only and should be kept away from children. A medication guide is available and can be printed from the website provided. The tablets are distributed by Advagen Pharma Limited and manufactured by Rubicon Research Private Limited in India.*

Diclofenac Sodium Delayed-Release Tablets are a medication used to treat pain and inflammation. Each tablet contains 75 mg of diclofenac sodium, and the usual dosage should be followed per the package insert. The tablets should be stored at room temperature and protected from moisture in a light-resistant container. This medication guide is to be distributed to each patient upon dispensing at a pharmacy. The drug is manufactured by Rubicon Research Private Limited in India and distributed by Advagen Pharma based in the United States.*

This is a medication called Diclofenac Sodium 56, distributed by Advagen Pharma Limited. The dosage is indicated in the package insert and the medication should be stored at a temperature between 20°C to 25°C. It comes in a delayed-release tablet form and should be kept out of reach of children. No further information is available.*

This is a medication information sheet for delayed-release tablets containing Diclofenac Sodium, USP with a dosage of 75mg. It is advised to store this medication in a tight, light-resistant, container at a room temperature of 20°C to 25°C, with excursions permitted between 15°C and 30°C. It's important to protect from moisture and keep out of reach of children. The medication guide should be given to each patient by the pharmacist. This product is manufactured by Rubicon Research Private Limited, India, and distributed by Advagen Pharma Limited in the USA.*

This is not a useful description. It seems to be a list of chemical compounds or elements, but without context or additional information it is unclear what they are referring to.*